↓ Skip to main content

Cochrane Database of Systematic Reviews

Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema

Overview of attention for article published in Cochrane database of systematic reviews, October 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
11 X users
facebook
1 Facebook page

Citations

dimensions_citation
59 Dimensions

Readers on

mendeley
172 Mendeley
Title
Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema
Published in
Cochrane database of systematic reviews, October 2019
DOI 10.1002/14651858.cd002312.pub4
Pubmed ID
Authors

Emile S Altmann, Iain Crossingham, Stephen Wilson, Huw R Davies

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 172 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 172 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 25 15%
Student > Master 16 9%
Researcher 14 8%
Student > Doctoral Student 11 6%
Other 11 6%
Other 22 13%
Unknown 73 42%
Readers by discipline Count As %
Medicine and Dentistry 55 32%
Pharmacology, Toxicology and Pharmaceutical Science 8 5%
Nursing and Health Professions 6 3%
Immunology and Microbiology 4 2%
Psychology 4 2%
Other 14 8%
Unknown 81 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 April 2023.
All research outputs
#4,634,886
of 24,614,554 outputs
Outputs from Cochrane database of systematic reviews
#7,115
of 12,946 outputs
Outputs of similar age
#89,230
of 368,657 outputs
Outputs of similar age from Cochrane database of systematic reviews
#135
of 203 outputs
Altmetric has tracked 24,614,554 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,946 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.9. This one is in the 45th percentile – i.e., 45% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 368,657 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 203 others from the same source and published within six weeks on either side of this one. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.